ArticleWorld journal of gastroenterology2025
Peripheral blood lymphocyte subset deficiency in acute-on-chronic liver failure and reconstitution following liver transplantation.
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with acute-on-chronic liver failure (ACLF) experience severe immune dysfunction. Liver transplantation (LT) significantly improves survival outcomes. However, the characteristics of peripheral blood lymphocyte subsets (PBLSs) in this patient population are not well defined, and the dynamics of immune reconstitution post-LT are insufficiently understood.
aimTo characterize PBLSs in patients with ACLF prior to LT and to evaluate PBLS reconstitution after LT.
methodsClinical data from patients undergoing LT in the Transplantation Center, The Third Xiangya Hospital from January 2022 to December 2023 were analyzed retrospectively. Our cohort comprised 44 patients with ACLF, 16 patients with acute decompensation of cirrhosis, and 23 patients with compensated cirrhosis. Twenty healthy volunteers were included as controls. PBLSs were evaluated across all groups. The relationship between PBLSs and post-LT prognosis was assessed, and dynamic changes in PBLSs among patients with ACLF were analyzed at different time points.
resultsPatients with ACLF exhibited a marked reduction in PBLSs compared with healthy volunteers. Natural killer (NK) cell counts were further reduced in patients with ACLF when compared with patients with compensated cirrhosis. PBLSs did not correlate with the etiology or severity of ACLF or with established liver failure scores. Following LT, a rapid restoration of NK cells and B cells was observed in patients with ACLF. However, the cluster of differentiation (CD) 3
conclusionPatients with ACLF exhibited markedly reduced PBLSs, with decreased NK cells potentially linked to progression from compensated cirrhosis to liver failure. NK and B cell were rapidly restored after LT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.